[图书][B] Candida and candidosis: a review and bibliography. 2nd edition.

FC Odds - 1988 - cabidigitallibrary.org
The author is one of the most distinguished workers in the field of candidiasis and the book
is an impressive overview of this ever-expanding subject. This is the second edition and …

How chemotherapy increases the risk of systemic candidiasis in cancer patients: current paradigm and future directions

F Teoh, N Pavelka - Pathogens, 2016 - mdpi.com
Candida albicans is a fungal commensal and a major colonizer of the human skin, as well
as of the gastrointestinal and genitourinary tracts. It is also one of the leading causes of …

Evidence for macrophage-mediated protection against lethal Candida albicans infection

F Bistoni, A Vecchiarelli, E Cenci, P Puccetti… - Infection and …, 1986 - Am Soc Microbiol
Systemic infection of mice with a Candida albicans strain (PCA-2) incapable of yeast-
mycelial conversion conferred protection against a subsequent intravenous challenge with …

Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida …

C Steinmüller, J Roesler, E Gröttrup, G Franke… - International Journal of …, 1993 - Elsevier
Polysaccharides (EP) isolated from large scale plant cell cultures of Echinacea purpurea,
have been shown to activate human and murine phagocytes. In this study we investigated …

Effects of cyclophosphamide on the immune system and disease resistance of Asian catfish Clarias batrachus

J Kumari, PK Sahoo - Fish & Shellfish Immunology, 2005 - Elsevier
Cyclophosphamide (CYP), a multifunctional alkylating agent is known as a potent
immunosuppressor in endotherms. Here, an experiment was conducted in an ectothermic …

Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of …

F Bistoni, G Verducci, S Perito… - Journal of medical …, 1988 - Taylor & Francis
Systemic infection of mice with a Candida albicans strain (PCA-2) incapable of yeast-
mycelial conversion is known to activate host macrophages and confer protection against …

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes

K Richardson, KW Brammer, MS Marriott… - Antimicrobial agents …, 1985 - Am Soc Microbiol
The therapeutic potential of UK-49,858, a difluorophenyl bis-triazole derivative, has been
assessed by evaluating its activity against systemic infections with Candida albicans in …

Pathogenicity of basidiospores of Filobasidiella neoformans var. neoformans

S Sukroongreung, K Kitiniyom, C Nilakul… - Medical …, 1998 - academic.oup.com
Basidiospores of Filobasidiella neoformans var. neoformans (progeny of Cryptococcus
neoformans MT 100· 1× VR 45980) were able to induce cryptococcosis in Swiss albino mice …

Interleukin‐4 and‐10 exacerbate candidiasis in mice

L Tonnetti, R Spaccapelo, E Cenci… - European Journal of …, 1995 - Wiley Online Library
Neutralization of endogenous interleukin (IL)‐4 or IL‐10 in mice with Candida albicans
infection initiates or accelerates development of a T helper (Th) 1‐associated protective …

Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state

A Vecchiarelli, E Cenci, M Puliti, E Blasi, P Puccetti… - Cellular …, 1989 - Elsevier
A low-virulence, agerminative strain of Candida albicans (PCA-2) is able to confer a high
degree of nonspecific protection against subsequent challenge with highly virulent …